293 related articles for article (PubMed ID: 18240449)
1. Non-AIDS-defining cancers: should antiretroviral therapy be initiated earlier?
Cinti SK; Gandhi T; Riddell J
AIDS Read; 2008 Jan; 18(1):18-20, 26-32. PubMed ID: 18240449
[TBL] [Abstract][Full Text] [Related]
2. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
[TBL] [Abstract][Full Text] [Related]
3. AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era.
Silverberg MJ; Abrams DI
Curr Opin Oncol; 2007 Sep; 19(5):446-51. PubMed ID: 17762569
[TBL] [Abstract][Full Text] [Related]
4. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS.
Hessol NA; Pipkin S; Schwarcz S; Cress RD; Bacchetti P; Scheer S
Am J Epidemiol; 2007 May; 165(10):1143-53. PubMed ID: 17344204
[TBL] [Abstract][Full Text] [Related]
5. The epidemiology of acquired immunodeficiency syndrome malignancies.
Goedert JJ
Semin Oncol; 2000 Aug; 27(4):390-401. PubMed ID: 10950365
[TBL] [Abstract][Full Text] [Related]
6. [AIDS associated cancers in the era of highly active antiretroviral therapy (HAART)].
Tserenpuntsag B; Kołacińska A; Jabłonowska E
Przegl Epidemiol; 2007; 61(3):529-34. PubMed ID: 18069390
[TBL] [Abstract][Full Text] [Related]
7. HIV infection and cancer in the era of highly active antiretroviral therapy (Review).
Barbaro G; Barbarini G
Oncol Rep; 2007 May; 17(5):1121-6. PubMed ID: 17390054
[TBL] [Abstract][Full Text] [Related]
8. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.
Louie JK; Hsu LC; Osmond DH; Katz MH; Schwarcz SK
J Infect Dis; 2002 Oct; 186(7):1023-7. PubMed ID: 12232845
[TBL] [Abstract][Full Text] [Related]
9. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
Cheung MC; Pantanowitz L; Dezube BJ
Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
[TBL] [Abstract][Full Text] [Related]
10. Risk of cancers during interrupted antiretroviral therapy in the SMART study.
Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI
AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103
[TBL] [Abstract][Full Text] [Related]
11. A prevalence of posttransplantation cancers compared with cancers in people with human immunodeficiency virus/acquired immunodeficiency syndrome after highly active antiretroviral therapy.
Srisawat N; Avihingsanon A; Praditpornsilpa K; Jiamjarasrangsi W; Eiam-Ong S; Avihingsanon Y
Transplant Proc; 2008 Oct; 40(8):2677-9. PubMed ID: 18929833
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic approaches to AIDS-related malignancies.
Berretta M; Cinelli R; Martellotta F; Spina M; Vaccher E; Tirelli U
Oncogene; 2003 Sep; 22(42):6646-59. PubMed ID: 14528290
[TBL] [Abstract][Full Text] [Related]
13. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.
Powles T; Robinson D; Stebbing J; Shamash J; Nelson M; Gazzard B; Mandelia S; Møller H; Bower M
J Clin Oncol; 2009 Feb; 27(6):884-90. PubMed ID: 19114688
[TBL] [Abstract][Full Text] [Related]
14. Non--AIDS-defining malignancies in HIV.
Mitsuyasu RT
Top HIV Med; 2008; 16(4):117-21. PubMed ID: 18838745
[TBL] [Abstract][Full Text] [Related]
15. The growing problem of non-AIDS-defining malignancies in HIV.
Pantanowitz L; Schlecht HP; Dezube BJ
Curr Opin Oncol; 2006 Sep; 18(5):469-78. PubMed ID: 16894295
[TBL] [Abstract][Full Text] [Related]
16. Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation.
Grulich AE
Curr Opin HIV AIDS; 2009 May; 4(3):183-7. PubMed ID: 19532048
[TBL] [Abstract][Full Text] [Related]
17. Clinical presentation and outcome of non-AIDS defining cancers, in HIV-infected patients in the ART-era: the Italian Cooperative Group on AIDS and tumors activity.
Berretta M; Martellotta F; Di Francia R; Spina M; Vaccher E; Balestreri L; Borsatti E; Bearz A; De Paoli P; Tirelli U
Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3619-34. PubMed ID: 26502852
[TBL] [Abstract][Full Text] [Related]
18. Review of screening guidelines for non-AIDS-defining malignancies: evolving issues in the era of highly active antiretroviral therapy.
Tyerman Z; Aboulafia DM
AIDS Rev; 2012; 14(1):3-16. PubMed ID: 22297500
[TBL] [Abstract][Full Text] [Related]
19. Update: cancer risk in persons with HIV/AIDS in the era of combination antiretroviral therapy.
Grulich AE
AIDS Read; 2000 Jun; 10(6):341-6. PubMed ID: 10881365
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of cancer risk late after AIDS onset in the United States.
Simard EP; Pfeiffer RM; Engels EA
Arch Intern Med; 2010 Aug; 170(15):1337-45. PubMed ID: 20696958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
